Last updated on March 2018

Efficacy and Safety Study as Add-on Therapy of SA237 to Treat NMO and NMOSD

Brief description of study

The objective of this study is to evaluate the efficacy, safety, pharmacodynamic, pharmacokinetic and immunogenic profiles of SA237 in patients with NMO and NMOSD

Detailed Study Description

Recruitment is closed to adults. Recruitment is open to adolescents 12-17 years old.

Clinical Study Identifier: NCT02028884

Contact Investigators or Research Sites near you

Start Over